The H163A mutation unravels an oxidized conformation of the SARS-CoV-2 main protease
Description
The main protease of SARS-CoV-2 (Mpro) is an important target for developing COVID-19 therapeutics. Recent work has highlighted Mpro's susceptibility to undergo redox-associated conformational changes in response to cellular and immune-system-induced
